Using our unique 3M3 tissue regeneration platform, which utilizes adipose-derived stem cells within a 3-dimensional extracellular matrix, to drive multiple product classes, Novadip’s mission is to provide innovative solutions for patients with limited or no effective treatment options.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
autologous bone tissue engineered product for orphan indication of critical size bone defect
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):